Hepatitis C News

BOSTON — Residents who learn to screen and treat patients for hepatitis C virus infection in a primary care setting reported feeling more comfortable prescribing treatment, with improved screening rates reported, according to a poster.

BOSTON — Nancy S. Reau, MD, FAASLD, AGAF, spoke with Healio about results from the END C study, which evaluated a community-based care model for hepatitis C virus infection among individuals at multiple community homeless sites in England.

BOSTON — In this video, Nancy S. Reau, MD, FAASLD, AGAF, reviews three abstracts presented at The Liver Meeting related to pregnancy and pediatric treatments for hepatitis C virus infection.

BOSTON — According to an abstract at The Liver Meeting, patients of Hispanic ethnicity who had elevated liver enzymes at baseline remained at increased risk for hepatocellular carcinoma, despite spontaneously clearing hepatitis C virus.

BOSTON — Use of directly observed therapy was successful even at extended intervals when treating hepatitis C virus infection among people who inject drugs, according to research presented at The Liver Meeting.

BOSTON — A regimen of sofosbuvir/velpatasvir with ribavirin was effective among patients with refractory chronic hepatitis C virus with liver cirrhosis and chronic kidney disease, according to data presented at The Liver Meeting.

BOSTON — A virtual treatment program that coordinates care with local providers improved therapy for children and adolescents with hepatitis C virus in the United Kingdom, according to a presentation at The Liver Meeting.

BOSTON — Implementation of universal hepatitis C virus screening at cancer centers and corresponding care may positively affect HCV elimination targets and improve public health outcomes, according to a presentation at The Liver Meeting.

BOSTON — There is a reduction in syringe sharing when methadone providers are spread out near areas with the greatest density of people who inject drugs, according to research presented at The Liver Meeting.

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, discusses data from The Liver Meeting on treatment of hepatitis C virus infection among individuals with hepatocellular carcinoma.